Gut bacteria from menopausal mice improve ovarian health when transplanted into young females

Why it matters: Ovarian aging ends in menopause, which is linked to higher risks of osteoporosis and dementia. Later menopause is associated with longer lifespan. Despite this, little is known about what drives ovarian aging or how to slow it. Gut bacteria are already linked to female reproductive health through estrogen metabolism (the 'estrobolome'), polycystic ovary syndrome and premature ovarian insufficiency. This raises the question of whether the microbiome directly shapes ovarian aging.

What was studied: The team profiled fecal microbiota by 16S rRNA sequencing in young (4-month) and naturally aged, estropausal (20-month) C57BL/6JNia female mice. Animals came from four independent cohorts (n=20 young, n=19 estropausal). They also built a composite 'ovarian health index', modeled on the frailty index. It combines follicle counts with serum AMH, FSH and Inhibin A, each scored on a three-tier scale anchored to young and estropausal medians, and the authors released a free online calculator. They then performed fecal microbiota transplantation (FMT) from young or estropausal donors into young female recipients. They assessed ovarian transcriptomes by RNA-seq, ovarian health and fertility. Finally, they integrated metagenomics-based causal mediation analysis with untargeted serum metabolomics.

Key results: Estropausal mice had lower follicle counts (P~0.0065), lower AMH (P~0.0079) and a worse ovarian health index (P~0.0117) than young mice. Their gut microbiota also differed clearly in community structure and in alpha-diversity measures (observed features P~9.1×10⁻⁴; Shannon entropy P~9.7×10⁻⁶). Differential abundance analysis (ALDEx2) and functional prediction (PICRUSt2) were performed. Predicted microbial β-glucuronidase activity did not differ significantly between groups (P~0.38). Per the abstract, heterochronic FMT of estropausal microbiota into young recipients remodeled the ovarian transcriptome. It reduced inflammation-related gene expression and dampened genes upregulated in aging ovaries, which the authors describe as features consistent with ovarian rejuvenation. These changes were accompanied by improved ovarian health measures and increased fertility. Mediation analysis nominated candidate microbial genera and species, and serum metabolites, that may contribute to these effects.

Implications: The result is counterintuitive, since aged microbiota benefited young ovaries. It also fits the mixed literature on aged-to-young FMT, where outcomes vary by organ and context. It supports a causal role for the gut microbiome in ovarian function. It also points toward testable microbial or metabolite interventions for ovarian aging, and it provides a standardized index for comparing ovarian health across studies.

Caveats: This is a mouse study. The full text available for this summary covered the introduction and the first results section, so FMT, fertility, mediation and metabolomics details are taken from the abstract. The mediation-derived species and metabolites are candidates, not proven mediators. Human translation is untested.